Delayed Surgical Management of Acute Type A Aortic Dissection in a Patient with Recent COVID-19 Infection and Post-COVID-19 Bronchopneumonia-Case Report and Review of Literature.
Mircea RobuDiana Romina MarianRasvan VasileBogdan RadulescuAlice StegaruCristian VoicaClaudia NicaDaniela GheorghitaOndin ZahariaIulian-Vasile AntoniacAngelica MoldovanVictor PavelHorațiu MoldovanVlad Anton IliescuPublished in: Medicina (Kaunas, Lithuania) (2022)
Ever since it was first described in 1760, acute type A aortic dissection has created difficulties in its management. The recent COVID-19 pandemic revealed that extrapulmonary manifestations of this condition may occur, and recent reports suggested that aortic dissection may be amongst them since it shares a common physiopathology, that is, hyper-inflammatory syndrome. Cardiac surgery with cardiopulmonary bypass in the setting of COVID-19-positive patients carries a high risk of postoperative respiratory failure. While the vast majority accept that management of type A aortic dissection requires urgent surgery and central aortic therapy, there are some reports that advocate for delaying surgery. In this situation, the risk of aortic rupture must be balanced with the possible benefits of delaying urgent surgery. We present a case of acute type A dissection with COVID-19-associated bronchopneumonia successfully managed after delaying surgery for 6 days.
Keyphrases
- aortic dissection
- minimally invasive
- coronary artery bypass
- coronavirus disease
- sars cov
- respiratory failure
- cardiac surgery
- surgical site infection
- ejection fraction
- patients undergoing
- extracorporeal membrane oxygenation
- acute kidney injury
- single cell
- emergency department
- respiratory syndrome coronavirus
- heart failure
- acute coronary syndrome
- adverse drug
- pulmonary hypertension
- atrial fibrillation
- left ventricular
- hepatitis b virus
- drug induced
- smoking cessation